4.6 Article

A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Postural Dynamics Are Associated With Cognitive Decline in Parkinson's Disease

Annette Pantall et al.

FRONTIERS IN NEUROLOGY (2018)

Review Clinical Neurology

Apathy and noradrenaline: silent partners to mild cognitive impairment in Parkinson's disease?

Leyla Loued-Khenissi et al.

CURRENT OPINION IN NEUROLOGY (2015)

Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Article Clinical Neurology

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease

Chandana Buddhala et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)

Review Clinical Neurology

The neurobiological basis of cognitive impairment in Parkinson's disease

Glenda M. Halliday et al.

MOVEMENT DISORDERS (2014)

Review Clinical Neurology

Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus

Yvette A. M. Grimbergen et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)

Article Clinical Neurology

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

Mariese A. Hely et al.

MOVEMENT DISORDERS (2008)

Review Clinical Neurology

Clinical diagnostic criteria for dementia associated with Parkinson's disease

Murat Emre et al.

MOVEMENT DISORDERS (2007)

Article Clinical Neurology

The Parkinson's complex: Parkinsonism is just the tip of the iceberg

JW Langston

ANNALS OF NEUROLOGY (2006)

Review Cell Biology

Stages in the development of Parkinson's disease-related pathology

H Braak et al.

CELL AND TISSUE RESEARCH (2004)

Article Clinical Neurology

Construction of freezing of gait questionnaire for patients with Parkinsonism

N Giladi et al.

PARKINSONISM & RELATED DISORDERS (2000)